Magnesium%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520sulphate

# Magnesium Sulphate ## Overview Magnesium sulfate is an essential mineral that plays a vital role in numerous physiological processes. It is available for intravenous (IV) and intramuscular (IM) administration. ## Primary Indications * **Hypomagnesemia:** Treatment of low magnesium levels. * **Eclampsia/Preeclampsia:** Prevention and treatment of seizures associated with severe preeclampsia and eclampsia. * **Torsades de Pointes:** Treatment of polymorphic ventricular tachycardia. * **Bronchospasm:** Adjunctive treatment for severe acute asthma. ## Adult Dosing * **Hypomagnesemia:** * Severe: 4 to 6 g IV infused over 1 hour, followed by 2 g/hour infusion or 1 g IM every 4 hours as needed. * Mild to moderate: 1 to 2 g IV or IM every 4 to 6 hours. * **Eclampsia/Preeclampsia (loading dose):** 4 to 6 g IV over 5 to 10 minutes. * **Eclampsia/Preeclampsia (maintenance dose):** 1 to 2 g/hour IV infusion. *Specific dosing may vary by institutional protocol.* * **Torsades de Pointes:** 1 to 2 g IV diluted in 10 mL of D5W and infused over 5 to 10 minutes. Repeat doses may be given. * **Bronchospasm:** 1.2 to 2 g IV infused over 15 to 20 minutes. ## Pediatric Dosing Dosing in pediatric patients is highly variable and depends on indication and patient weight. Consultation with a pediatric specialist or adherence to institutional protocols is recommended. * **Hypomagnesemia:** Generally dosed as 25-50 mg/kg/dose IV or IM every 4-6 hours. Maximum single dose typically 2 g. * **Eclampsia:** Pediatric dosing protocols are not well-established and institutional guidance should be followed. ## Dose Adjustments * **Renal Impairment:** Magnesium is renally excreted. Use with caution in patients with renal impairment. Reduce dose and monitor magnesium levels closely. * Mild to moderate impairment: Reduce dose by 50%. * Severe impairment: Avoid use if possible; if necessary, reduce dose by 75-100% and monitor serum magnesium. * **Hepatic Impairment:** No specific dose adjustment is typically required, but monitor magnesium levels, especially if concomitant renal impairment exists. ## Contraindications * Hypermagnesemia. * Heart block. * Myocardial infarction with hemodynamic instability. * Certain neuromuscular blockade agents (use with caution). ## Adverse Effects * **Common:** Flushing, sweating, nausea, vomiting, hypotension. * **Serious:** Respiratory depression, cardiac arrest, loss of deep tendon reflexes, hypocalcemia, hyperkalemia, CNS depression. ## Key Drug Interactions * **Neuromuscular Blockers:** Magnesium can potentiate the effects of neuromuscular blocking agents, leading to prolonged muscle relaxation and respiratory depression. * **Calcium Channel Blockers:** Additive hypotensive effects and potential for enhanced cardiac depression. * **Digitalis:** High doses of magnesium can cause arrhythmias in patients taking digitalis. * **Tetracyclines, Bisphosphonates, Nitrofurantoin, Fluoroquinolones:** Oral magnesium can decrease the absorption of these drugs; separate administration by at least 2 hours. ## Monitoring * **Serum Magnesium Levels:** Essential, especially with prolonged therapy, renal impairment, or high doses. Target levels vary by indication but generally aim for 4-7 mEq/L (2-3.5 mmol/L) for hypomagnesemia. * **Renal Function:** Monitor creatinine. * **Deep Tendon Reflexes:** Assess for presence and normality. Loss of reflexes may indicate hypermagnesemia. * **Respiratory Rate and Effort:** Monitor for signs of respiratory depression. * **Electrocardiogram (ECG):** Monitor for changes suggestive of cardiac toxicity. * **Urine Output:** Adequate urine output is necessary for magnesium excretion. ## Clinical Pearls * Rapid IV infusion can cause hypotension and cardiac arrhythmias. Infuse slowly and monitor vital signs. * Monitor for signs and symptoms of hypermagnesemia, particularly in patients with impaired renal function or receiving high doses. * Magnesium sulfate is an antidote for barium poisoning. * In the management of eclampsia, magnesium sulfate is typically the drug of choice for seizure prophylaxis and treatment. --- **Educational Disclaimer:** This information is intended for clinical decision support and does not replace the need to consult the official prescribing information and current clinical guidelines. Always verify current drug information and institutional protocols before prescribing.